European perspectives on pediatric formulations

Clinical Therapeutics

Volumn 30, Issue 11, 2008, Pages 2146-2154

  Breitkreutz, Jörg ^a  

^a HEINRICH HEINE UNIVERSITY   (Germany)

Author keywords

drug formulations; European Union; pediatrics; regulations

Indexed keywords

ARTICLE; CHILD CARE; DRUG DOSAGE FORM; DRUG FORMULATION; DRUG INDUSTRY; DRUG RESEARCH; EUROPEAN UNION; HEALTH CARE POLICY; MEDICAL SOCIETY; TASTE ACUITY; UNITED STATES; WORLD HEALTH ORGANIZATION;

CHEMISTRY, PHARMACEUTICAL; CHILD; EUROPEAN UNION; GUIDELINES AS TOPIC; HUMANS; PEDIATRICS;

EID: 57849084850     PISSN: 01492918     EISSN: 1879114X     Source Type: Journal    
DOI: 10.1016/j.clinthera.2008.11.016     Document Type: Article

References (48)

1. US Food and Drug Administration. FDA's information on the Modernization Act of 1997.
2. (November 19, 2008). http://www.fda.gov/cdrh/modact/modern.html Accessed
3. Conroy S., Choonara I., Impicciatore P., et al., for the European Network for Drug Investigation in Children. Survey of unlicensed and off label drug use in paediatric wards in European countries. BMJ 320 (2000) 79-82
4. Turner S., Nunn A.J., and Choonara I. Unlicensed drug use in children in the UK. Paed Perinat Drug Ther 1 (1997) 52-55
5. Regulation (EC) No. 1901/2006 of the European Parliament and of the Council of December 12, 2006, on medicinal products for paediatric use and amending Regulation (EEC) No. 1768/92, Directive 2001/20/EC, Directive 2001/83/EC and Regulation (EC) No. 726/2004.
6. (November 11, 2008). http://eur-lex.europa.eu/LexUriServ/LexUriServ.do?uri=OJ:L:2006:378:0001 :0019:EN:PDF Accessed
7. European Union institutions and other bodies.
8. (November 11, 2008). http://europa.eu/institutions/index_en.htm Accessed
9. European Commission. Notice to applicants. Vol. 2A. Procedures for marketing authorisation. Chapter 2. Mutual recognition.
10. (November 11, 2008). http://ec.europa.eu/enterprise/pharmaceuticals/eudralex/vol-2/a/vol2a_ch ap2_2005-11.pdf Accessed
11. Rote Liste 2008 (2008), Rote Liste Service GmbH, Frankfurt, Germany
12. Saint-Raymond A., and Seigneuret N. Medicines for children: Time for Europe to act. Paed Perinat Drug Ther 6 (2005) 142-146
13. Choonara I., and Bonati M. European legislation to improve medicines for children. Paed Perinat Drug Ther 8 (2007) 2-3
14. ICH Topic E 11: Clinical investigation of medicinal products in the paediatric population (CPMP/ICH/2711/99).
15. (November 11, 2008). http://www.emea.europa.eu/pdfs/human/ich/271199en.pdf Accessed
16. Committee for Medicinal Products for Human Use (CHMP). Reflection paper: Formulations of choice for the paediatric population.
17. (November 11, 2008). http://www.emea.europa.eu/pdfs/human/paediatrics/19481005en.pdf Accessed
18. Schirm E., Tobi H., de Vries T.W., et al. Lack of appropriate formulations of medicines for children in the community. Acta Paediatr 92 (2003) 1486-1489
19. Yeung V.W., and Wong I.C. When do children convert from liquid antiretroviral to solid formulations?. Pharm World Sci 27 (2005) 399-402
20. Everard M.L. Inhaler devices in infants and children: Challenges and sol utions. J Aerosol Med 17 (2004) 186-195
21. Breitkreutz J., and Boos J. Paediatric and geriatric drug delivery. Expert Opin Drug Deliv 4 (2007) 37-45
22. Ernest T.B., Elder D.P., Martini L.G., et al. Developing paediatric medicines: Identifying the needs and recogniz ing the challenges. J Pharm Pharmacol 59 (2007) 1043-1055
23. Throm S. Activities of the PDCO [in German]. Pharm Ind 70 (2008) 729
24. Pediatric Research EquityAct(2003).
25. (November 11, 2008). http://frwebgate.access.gpo.gov/cgibin/getdoc.cgi?dbname=108_cong_ public_laws&docid=f:publ155.108 Accessed
26. Martin A. New regulation of children's medicines. Pharm Technol Eur 19 (2007) 19-20
27. European Medicines Agency (EMEA). Recommendation of the Paediatric Committee to the European Com mission regarding the symbol (December 20, 2007), EMEA/498247/2007.
28. (November 21, 2008). http://www.emea.europa.eu/pdfs/human/paediatrics/49824707en.pdf Accessed
29. European Commission (EC). Commission at present not in a position to select a symbol for medicines authorised for a paediatric indication (January 30, 2008).
30. (November 11, 2008). http://ec.europa.eu/enterprise/pharmaceuticals/paediatrics/medchild_key_ en.htm Accessed
31. European Medicines Agency (EMEA). The network of paediatric networks at the EMEA implementing strategy (January 15, 2008). EMEA/MB/543523/2007.
32. (November 21, 2008). http://www.emea.europa.eu/pdfs/human/paediatrics/54352307en.pdf Accessed
33. European Medicines Agency (EMEA). Medicines for children: Paediatric needs.
34. (November 11, 2008). http://www.emea.europa.eu/htms/human/paediatrics/inventory.htm Accessed
35. European Medicines Agency (EMEA). Revised priority list for studies into off-patent paediatric medicinal products, EMEA/226983/2008.
36. (November 21, 2008). http://www.emea.europa.eu/pdfs/human/paediatrics/22698308en.pdf Accessed
37. Krause J., and Breitkreutz J. Improving drug delivery in pediatric medicine. Pharm Med 22 (2008) 41-50
38. Pawar S., and Kumar A. Issues in the formulation of drugs for oral use in children: Role of excipients. Paediatr Drugs 4 (2002) 371-379
39. American Academy of Pediatrics. "Inactive" ingredients in pharmaceutical products. Committee on Drugs. Pediatrics 76 (1985) 635-643
40. European Medicines Agency (EMEA). Medicines for children: Scientific guidance.
41. (November 11, 2008). http://www.emea.europa.eu/htms/human/paediatrics/sci_gui.htm Accessed
42. European Medicines Agency (EMEA). Medicines for children: Global cooperations: Workshops.
43. (November 11, 2008). http://www.emea.europa.eu/htms/human/paediatrics/workshops.htm Accessed
44. Choonara I., and Bauchner H. Publishing the evidence for children's medicine. Arch Dis Child 93 (2008) 815
45. Breitkreutz J., Wessel T., and Boos J. Dosage forms for peroral drug administration to children. Paed Perin Drug Ther 3 (1999) 25-33
46. Skwierczynski C., and Conroy S. How long does it take to administer oral medicines to children?. Paed Perin Drug Ther 8 (2008) 145-149
47. Woods D.J. Extemporaneous formulations-problems and solutions. Paed Perin Drug Ther 1 (1997) 25-29
48. Cram A, Breitkreutzj, Desset-Brèthes S, et al, on behalf of the European Paediatric Formulation Initiative. Challenges of developing palatable oral paediatric formulations [published online ahead of print September 19, 2008]. Intj Pharm.